IGF1-LR3 1mg

$104.00

IGF-1 LR3 is a cutting-edge research peptide that holds promise across multiple fields, including muscle growth, fetal development, and the study of metabolic disorders. Engineered for enhanced stability and potency, IGF-1 LR3 is designed to extend the biological effects of insulin-like growth factor-1. As with all research peptides, its use should be carefully monitored under controlled conditions, with ongoing studies required to fully understand its potential benefits and risks in therapeutic applications.

Category:

Description

Referenced Citations

  1. Tomas, F. M., et al. (1993). Anabolic effects of insulin-like growth factor-I (IGF-I) and an IGF-I variant in normal female rats. Journal of Endocrinology, 137(3), 413-421. [Online].
    Available: https://pubmed.ncbi.nlm.nih.gov/8229461/
  2. Philippou, A., et al. (2007). The role of the insulin-like growth factor 1 (IGF-1) in skeletal muscle physiology. In Vivo, 21(1), 45-54. [Online].
    Available: https://pubmed.ncbi.nlm.nih.gov/17354613/
  3. Stremming, J., et al. (2021). IGF-1 Increases Fetal Organ Growth. Children’s Hospital Colorado. [Online].
    Available: https://www.childrenscolorado.org/advances-answers/recent-articles/igf1/
  4. Kolomin, T., et al. (2013). A new generation of drugs: synthetic peptides based on natural regulatory peptides. Neuroscience and Behavioral Physiology, 43(7), 880-891. [Online].
    Available: https://pubmed.ncbi.nlm.nih.gov/23864238/
  5. Qkine. (2024). Recombinant human/bovine/porcine IGF-1 LR3 protein (Qk041). [Online].
    Available: https://qkine.com/product/recombinant-human-igf1-lr3-protein-qk041/